Go to
JCI Insight
Citations to this article
A Oliva, … , J W Romano, A S Fauci
Published July 1, 1998
Citation Information: J Clin Invest. 1998;102(1):223-231. https://doi.org/10.1172/JCI2323.
Citation Information: J Clin Invest. 1998;102(1):223-231. https://doi.org/10.1172/JCI2323.
Abstract
Macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES (regulated on activation, normal T cell expressed and secreted), which are the natural ligands of the CC-chemokine receptor CCR5, inhibit replication of MT-2- negative strains of HIV-1 by interfering with the ability of these strains to utilize CCR5 as a coreceptor for entry in CD4(+) cells. The present study investigates the capacity of natural killer (NK) cells isolated from HIV-infected individuals to produce CC-chemokines and to suppress HIV replication in autologous, endogenously infected cells as well as to block entry of MT-2-negative HIV into the CD4(+) T cell line PM-1. NK cells freshly isolated from HIV-infected individuals had a high number of mRNA copies for MIP-1alpha and RANTES. NK cells produced significant amounts of RANTES, MIP-1alpha, and MIP-1beta constitutively, in response to stimulation with IL-2 alone and when they were performing their characteristic lytic activity (K562 killing). After CD16 cross-linking and stimulation with IL-2 or IL-15 NK cells produced CC-chemokines to levels comparable to those produced by anti-CD3-stimulated CD8(+) T cells. Furthermore, CD16 cross-linked NK cells suppressed (49-97%) viral replication in cocultures of autologous CD8/NK-depleted PBMC to a degree similar to that of PHA or anti-CD3-stimulated CD8(+) T cells. In 50% of patients tested, NK-mediated HIV suppression could be abrogated by neutralizing antibodies to MIP-1alpha, MIP-1beta and RANTES; in contrast, CD8(+) T cell-mediated suppression was not significantly overcome upon neutralization of CC-chemokines. Supernatants derived from cultures of CD16 cross-linked NK cells stimulated with IL-2 or IL-15 dramatically inhibited entry of a MT-2-negative strain of HIV, BaL, in the CD4(+)CCR5(+) PM-1 T cell line. These data suggest that activated NK cells may be an important source of CC-chemokines in vivo and may suppress HIV replication by CC-chemokine-mediated mechanisms in addition to classic NK-mediated lytic mechanisms.
Authors
A Oliva, A L Kinter, M Vaccarezza, A Rubbert, A Catanzaro, S Moir, J Monaco, L Ehler, S Mizell, R Jackson, Y Li, J W Romano, A S Fauci
Total citations by year
Citation information
Citations to this article (232)
| Title and authors | Publication | Year |
|---|---|---|
|
Enhancement of NK Cell Cytotoxic Activity and Immunoregulatory Effects of a Natural Product Supplement Across a Wide Age Span: A 30-Day In Vivo Human Study
Boichuk S, Galembikova A, Vollmer D |
International Journal of Molecular Sciences | 2025 |
|
Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications.
Letafati A, Ardekani OS, Naderisemiromi M, Norouzi M, Shafiei M, Nik S, Mozhgani SH |
Virology Journal | 2024 |
|
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Ji G, Yang Q, Wang S, Yan X, Ou Q, Gong L, Zhao J, Zhou Y, Tian F, Lei J, Mu X, Wang J, Wang T, Wang X, Sun J, Zhang J, Jia C, Jiang T, Zhao MG, Lu Q |
Genome Medicine | 2024 |
|
Positive impacts of Nannochloropsis oculata supplementation on gene expression of immune and antioxidant markers and metabolic profile of Barki sheep in the transition period and lipogenic effects on progeny.
El-Sayed A, Ebissy E, Ateya A |
Veterinary Research Communications | 2024 |
|
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets
Reschke R, Enk AH, Hassel JC |
International journal of molecular sciences | 2024 |
|
Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease.
Hameed M, Solomon NA, Weger-Lucarelli J |
bioRxiv : the preprint server for biology | 2024 |
|
Emerging Role of NK Cells in Non-AIDS Comorbidities During Suppressive Antiretroviral Therapy
Alles M, Demberg T, Liyanage NP |
Current opinion in HIV and AIDS | 2024 |
|
Non-Classical HLA Class 1b and Hepatocellular Carcinoma
De Re V, Tornesello ML, Racanelli V, Prete M, Steffan A |
Biomedicines | 2023 |
|
DNA Polymorphisms and mRNA Levels of Immune Biomarkers as Candidates for Inflammatory Postpartum Disorders Susceptibility in Italian Buffaloes.
Ateya A, Safhi FA, El-Emam H, Al-Ghadi MQ, Abdo M, Fericean L, Olga R, Mihaela O, Hizam MM, Mamdouh M, Abu El-Naga EM, Raslan WS |
Veterinary Sciences | 2023 |
|
Evaluation of Proinflammatory Chemokines in HIV Patients with Asymptomatic Leishmania Infantum Infection.
Monteiro BEF, da Silva ED, Bezerra GSN, Cavalcante MKA, Pereira VRA, Castro MCAB, Mendes LG, Guedes DL, Barbosa Júnior WL, de Medeiros ZM |
Tropical Medicine and Infectious Disease | 2023 |
|
So Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research
A Kleinman, I Pandrea, C Apetrei |
Viruses | 2022 |
|
Implications of the accumulation of CXCR5+ NK cells in lymph nodes of HIV-1 infected patients
A Guo, Y Jiao, Q Zhao, H Huang, J Deng, C Zhang, X Fan, R Xu, J Zhang, C Zhen, Z Xie, Y Qin, J Xu, Y Yang, M Shi, L Huang, J Song, F Wang |
EBioMedicine | 2022 |
|
Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
Bernard NF, Kant S, Kiani Z, Tremblay C, Dupuy FP |
Frontiers in immunology | 2022 |
|
NK Cells in Protection from HIV Infection.
Bernard NF, Alsulami K, Pavey E, Dupuy FP |
Viruses | 2022 |
|
Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance.
Duan S, Liu S |
Frontiers in immunology | 2022 |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
HIV Associated Neurocognitive Disorders Subsidence Through Citalopram Addition in Anti-retroviral Therapy (HANDS-CARE): A Concept Note
A Ojagbemi |
Frontiers in neurology | 2021 |
|
Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection
KP Devalraju, VS Neela, SS Krovvidi, R Vankayalapati, VL Valluri, S Subbian |
PloS one | 2021 |
|
Tumor Microenvironment: The Role of Chemokines – Part A
A Birbrair |
2020 | |
|
Tumor Microenvironment: The Role of Chemokines – Part A
A Birbrair |
2020 | |
|
Tumor Microenvironment: The Role of Chemokines – Part A
A Birbrair |
2020 | |
|
Tumor Microenvironment: The Role of Chemokines – Part A
A Birbrair |
2020 | |
|
Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment
I Navin, MT Lam, R Parihar |
Cancers | 2020 |
|
The protective potential of Fc‐mediated antibody functions against influenza virus and other viral pathogens
HA Vanderven, SJ Kent |
Immunology and Cell Biology | 2020 |
|
What Can Gamma Delta T Cells Contribute to an HIV Cure?
JA Juno, SJ Kent |
Frontiers in Cellular and Infection Microbiology | 2020 |
|
GeNeDis 2018: Computational Biology and Bioinformatics
P Vlamos |
2020 | |
|
GeNeDis 2018: Computational Biology and Bioinformatics
P Vlamos |
2020 | |
|
Relationship between expression pattern of vitamin D receptor, 1 alpha‐hydroxylase enzyme, and chemokine RANTES genes and selected serum parameters during transition period in Holstein dairy cows
HA Saed, HM Ibrahim, SA ElKhodery, MA Youssef |
Veterinary Record Open | 2020 |
|
HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1
Z Kiani, J Bruneau, DE Geraghty, NF Bernard, F Kirchhoff |
Journal of virology | 2019 |
|
The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells
Z Kiani, FP Dupuy, J Bruneau, B Lebouché, C Retière, DE Geraghty, NF Bernard, F Kirchhoff |
Journal of virology | 2019 |
|
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
CM Boudreau, G Alter |
Frontiers in immunology | 2019 |
|
Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections
SP Anand, A Finzi |
Human vaccines | 2019 |
|
The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection
A Lin, WH Yan |
Frontiers in immunology | 2019 |
|
Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models
JA Juno, KM Wragg, AB Kristensen, WS Lee, KJ Selva, RM van der Sluis, AD Kelleher, BR Bavinton, AE Grulich, SR Lewin, SJ Kent, MS Parsons, V Simon |
Journal of virology | 2019 |
|
Antibody-Dependent Cellular Cytotoxicity (ADCC) in HIV Infection:
DN Forthal, A Finzi |
AIDS | 2018 |
|
Baboon CD8 T cells suppress SIVmac infection in CD4 T cells through contact-dependent production of MIP-1α, MIP-1β, and RANTES
V Obregon-Perko, VL Hodara, LM Parodi, LD Giavedoni |
Cytokine | 2018 |
|
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
EO Saphire, SL Schendel, ML Fusco, K Gangavarapu, BM Gunn, AZ Wec, PJ Halfmann, JM Brannan, AS Herbert, X Qiu, K Wagh, S He, EE Giorgi, J Theiler, KB Pommert, TB Krause, HL Turner, CD Murin, J Pallesen, E Davidson, R Ahmed, MJ Aman, A Bukreyev, DR Burton, JE Crowe, CW Davis, G Georgiou, F Krammer, CA Kyratsous, JR Lai, C Nykiforuk, MH Pauly, P Rijal, A Takada, AR Townsend, V Volchkov, LM Walker, CI Wang, L Zeitlin, BJ Doranz, AB Ward, B Korber, GP Kobinger, KG Andersen, Y Kawaoka, G Alter, K Chandran, JM Dye |
Cell | 2018 |
|
HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1
Z Kiani, FP Dupuy, J Bruneau, B Lebouché, CX Zhang, E Jackson, I Lisovsky, S da Fonseca, DE Geraghty, NF Bernard |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
|
Pathogen recognition by NK cells amplifies the pro-inflammatory cytokine production of monocyte-derived DC via IFN-γ
T Oth, TH Habets, WT Germeraad, MI Zonneveld, GM Bos, J Vanderlocht |
BMC Immunology | 2018 |
|
A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells
KE Bowen, SO Mathew, K Borgmann, A Ghorpade, PA Mathew, AA Ansari |
PloS one | 2018 |
|
NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies
L Flórez-Álvarez, JC Hernandez, W Zapata |
Frontiers in immunology | 2018 |
|
Non-linear multidimensional flow cytometry analyses delineate NK cell phenotypes in normal and HIV-infected chimpanzees
C Manickam, H Li, SV Shah, K Kroll, RK Reeves |
International Immunology | 2018 |
|
Noncoding RNA in NK cells
C Yang, C Shen, T Feng, H Li |
Journal of leukocyte biology | 2018 |
|
Altered Cervical Mucosal Gene Expression and Lower Interleukin 15 Levels in Women With Schistosoma haematobium Infection but Not in Women With Schistosoma mansoni Infection
KM Dupnik, MH Lee, P Mishra, MJ Reust, S Colombe, SR Haider, B Yao, K Vick, T Zhang, J Xiang, D Miyaye, R Magawa, E Lyimo, C Mukerebe, J Mngara, SE Kalluvya, CJ de Dood, GJ van Dam, PL Corstjens, JA Downs |
The Journal of Infectious Diseases | 2018 |
|
Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity
NF Bernard, Z Kiani, A Tremblay-McLean, SA Kant, CE Leeks, FP Dupuy |
Frontiers in immunology | 2017 |
|
Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis?
JA Parra, NM Zúñiga, LA Zamudio, LA Álvarez, CS Lara, J Zúñiga |
Frontiers in immunology | 2017 |
|
Development of IFN-γ secretory ELISPOT based assay for screening of ADCC responses
A Shete, P Suryawanshi, C Chavan, A Kulkarni, S Godbole, M Ghate, M Thakar |
Journal of Immunological Methods | 2017 |
|
Antibody-dependent cellular cytotoxicity and influenza virus
HA Vanderven, S Jegaskanda, AK Wheatley, SJ Kent |
Current Opinion in Virology | 2017 |
|
Early Immune Responses to Marek's Disease Vaccines
M Heidari, D Wang, S Sun |
Viral Immunology | 2017 |
|
Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions
NF Bernard |
AIDS Research and Therapy | 2017 |
|
HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness
E Jackson, CX Zhang, Z Kiani, I Lisovsky, B Tallon, AD Corpo, L Gilbert, J Bruneau, R Thomas, P Côté, B Trottier, R LeBlanc, D Rouleau, C Tremblay, CM Tsoukas, JP Routy, X Ni, T Mabanga, NF Bernard, AA Ansari |
PloS one | 2017 |
|
Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells
E Littwitz-Salomon, U Dittmer, K Sutter |
Retrovirology | 2016 |
|
Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication
X He, CR Simoneau, ME Granoff, S Lunemann, AS Dugast, Y Shao, M Altfeld, C Körner |
Journal of Immunological Methods | 2016 |
|
The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection: Educated NKs respond differently to HIV iCD4
I Lisovsky, G Isitman, A Tremblay-McLean, R Song, S DaFonseca, B Lebouchẻ, JP Routy, J Bruneau, NF Bernard |
Clinical & Experimental Immunology | 2016 |
|
Encyclopedia of Signaling Molecules
S Choi |
Encyclopedia of Signaling Molecules | 2016 |
|
The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection: Educated NKs respond differently to HIV iCD4
I Lisovsky, G Isitman, A Tremblay-McLean, R Song, S DaFonseca, B Lebouchẻ, JP Routy, J Bruneau, NF Bernard |
Clinical & Experimental Immunology | 2016 |
|
Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity Implications for HIV Transmission
MS Parsons, V Madhavi, F Ana-Sosa-Batiz, RJ Center, KM Wilson, T Bunupuradah, K Ruxrungtham, SJ Kent |
Journal of acquired immune deficiency syndromes (1999) | 2016 |
|
Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis
AW Ansari, F Ahmad, D Meyer-Olson, A Kamarulzaman, R Jacobs, RE Schmidt |
Cellular and Molecular Life Sciences | 2015 |
|
NK cells after transplantation: friend or foe
U Hadad, O Martinez, SM Krams |
Immunologic Research | 2014 |
|
HIV-1 Vpu Antagonism of Tetherin Inhibits Antibody-Dependent Cellular Cytotoxic Responses by Natural Killer Cells
RA Alvarez, RE Hamlin, A Monroe, B Moldt, MT Hotta, GR Caprio, DS Fierer, V Simon, BK Chen |
Journal of virology | 2014 |
|
HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets
R Song, I Lisovsky, B Lebouché, JP Routy, J Bruneau, NF Bernard |
PLoS pathogens | 2014 |
|
High Frequencies of Polyfunctional CD8+ NK Cells in Chronic HIV-1 Infection Are Associated with Slower Disease Progression
F Ahmad, HS Hong, M Jackel, A Jablonka, IN Lu, N Bhatnagar, JM Eberhard, BA Bollmann, M Ballmaier, M Zielinska-Skowronek, RE Schmidt, D Meyer-Olson |
Journal of virology | 2014 |
|
NK Cell Responses to Simian Immunodeficiency Virus Vaginal Exposure in Naive and Vaccinated Rhesus Macaques
L Shang, AJ Smith, L Duan, KE Perkey, L Qu, S Wietgrefe, M Zupancic, PJ Southern, K Masek-Hammerman, RK Reeves, RP Johnson, AT Haase |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
|
Soluble Toll-like receptor 2 is significantly elevated in HIV-1 infected breast milk and inhibits HIV-1 induced cellular activation, inflammation and infection:
BM Henrick, XD Yao, AG Drannik, A Abimiku, KL Rosenthal |
AIDS | 2014 |
|
HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets
R Song, I Lisovsky, B Lebouché, JP Routy, J Bruneau, NF Bernard, RC Desrosiers |
PLoS pathogens | 2014 |
|
Influenza-Specific Antibody-Dependent Cellular Cytotoxicity: Toward a Universal Influenza Vaccine
S Jegaskanda, PC Reading, SJ Kent |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
|
Humanized Mice for HIV Research
LY Poluektova, JV Garcia, Y Koyanagi, MG Manz, AM Tager |
2014 | |
|
Neonatal natural killer cell function: relevance to antiviral immune defense
YC Lee, SJ Lin |
Clinical & developmental immunology | 2013 |
|
Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing after Myocardial Infarction by Aggravation of Inflammation
C Pachel, D Mathes, B Bayer, C Dienesch, G Wangorsch, W Heitzmann, I Lang, H Ardehali, G Ertl, T Dandekar, H Wajant, S Frantz, N Frangogiannis |
PloS one | 2013 |
|
The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1
C Guzzo, J Fox, Y Lin, H Miao, R Cimbro, BF Volkman, AS Fauci, P Lusso |
PLoS pathogens | 2013 |
|
Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity
A Jacobson, F Bell, N Lejarcegui, C Mitchell, L Frenkel, H Horton |
PloS one | 2013 |
|
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1
C Guzzo, J Fox, Y Lin, H Miao, R Cimbro, BF Volkman, AS Fauci, P Lusso, A Trkola |
PLoS pathogens | 2013 |
|
Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity
A Jacobson, F Bell, N Lejarcegui, C Mitchell, L Frenkel, H Horton, JK Sandberg |
PloS one | 2013 |
|
HIV RNA Suppression and Immune Restoration: Can We Do Better?
MR Pinzone, MD Rosa, B Cacopardo, G Nunnari |
Clinical and Developmental Immunology | 2012 |
|
Increasing the Clinical Efficacy of NK and Antibody-Mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Based on Observations in High-Risk Neuroblastoma
TA Koehn, LL Trimble, KL Alderson, AK Erbe, KA McDowell, B Grzywacz, JA Hank, PM Sondel |
Frontiers in pharmacology | 2012 |
|
The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
BK Brown, L Wieczorek, G Kijak, K Lombardi, J Currier, M Wesberry, JC Kappes, V Ngauy, M Marovich, N Michael, C Ochsenbauer, DC Montefiori, VR Polonis |
PloS one | 2012 |
|
HIV-1 Vpu Interference with Innate Cell-mediated Immune Mechanisms
JK Sandberg, SK Andersson, SM Bächle, DF Nixon, M Moll |
Current HIV research | 2012 |
|
Effect of Recombinant Cytokines on the Expression of Natural Killer Cell Receptors from Patients with TB or/and HIV Infection
VR Parasa, R Sikhamani, A Raja |
PloS one | 2012 |
|
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
N Vey, JH Bourhis, N Boissel, D Bordessoule, T Prebet, A Charbonnier, A Etienne, P Andre, F Romagne, D Benson, H Dombret, D Olive |
Blood | 2012 |
|
A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays
MD Alpert, LN Heyer, DE Williams, JD Harvey, T Greenough, M Allhorn, DT Evans |
Journal of virology | 2012 |
|
Effect of Recombinant Cytokines on the Expression of Natural Killer Cell Receptors from Patients with TB or/and HIV Infection
VR Parasa, R Sikhamani, A Raja, D Unutmaz |
PloS one | 2012 |
|
The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
BK Brown, L Wieczorek, G Kijak, K Lombardi, J Currier, M Wesberry, JC Kappes, V Ngauy, M Marovich, N Michael, C Ochsenbauer, DC Montefiori, VR Polonis, M Lichterfeld |
PloS one | 2012 |
|
Effects on Innate Immunity of a Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection
J Peña, M Frías, L Castro-Orgaz, R González, F García, T Gallart, JM Gatell, M Plana |
Viral Immunology | 2012 |
|
HIV vaccines: progress to date.
Munier CM, Andersen CR, Kelleher AD |
Drugs | 2011 |
|
NK cells and their receptors during viral infections
E Marcenaro, S Carlomagno, S Pesce, MD Chiesa, S Parolini, A Moretta, S Sivori |
Immunotherapy | 2011 |
|
The role of IL-15 in challenging Acquired Immunodeficiency Syndrome
G d’Ettorre, M Andreotti, G Ceccarelli, CM Galluzzo, A Mallano, AP Massetti, F Tierno, S Stella, R Amici, S Vella, CM Mastroianni, V Vullo |
Cytokine | 2011 |
|
Acupuncture May Stimulate Anticancer Immunity via Activation of Natural Killer Cells
MF Johnston, EO Sánchez, NL Vujanovic, W Li |
Evidence-Based Complementary and Alternative Medicine | 2011 |
|
Human Immunodeficiency Virus Type 1 Infection Is Associated with Increased NK Cell Polyfunctionality and Higher Levels of KIR3DL1+ NK Cells in Ugandans Carrying the HLA-B Bw4 Motif
MA Eller, RN Koehler, GH Kijak, LA Eller, D Guwatudde, MA Marovich, NL Michael, MS de Souza, F Wabwire-Mangen, ML Robb, JR Currier, JK Sandberg |
Journal of virology | 2011 |
|
The Chemokine System in Experimental and Clinical Hematology
O Bruserud |
2010 | |
|
The Chemokine System in Experimental and Clinical Hematology
O Bruserud |
2010 | |
|
The Chemokine System in Experimental and Clinical Hematology
O Bruserud |
2010 | |
|
The Chemokine System in Experimental and Clinical Hematology
O Bruserud |
2010 | |
|
The Chemokine System in Experimental and Clinical Hematology
O Bruserud |
2010 | |
|
The Chemokine System in Experimental and Clinical Hematology
O Bruserud |
2010 | |
|
The Chemokine System in Experimental and Clinical Hematology
O Bruserud |
2010 | |
|
Innate and Adaptive Factors Regulating Human Immunodeficiency Virus Type 1 Genomic Activation
S Shah, MR Nonnemacher, V Pirrone, B Wigdahl |
Journal of Neuroimmune Pharmacology | 2010 |
|
Innate immunity and chronic immune activation in HCV/HIV-1 co-infection
VD Gonzalez, AL Landay, JK Sandberg |
Clinical Immunology | 2010 |
|
Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication
T Gaufin, RM Ribeiro, R Gautam, J Dufour, D Mandell, C Apetrei, I Pandrea |
Retrovirology | 2010 |
|
CD56 negative NK cells: origin, function, and role in chronic viral disease
NK Björkström, HG Ljunggren, JK Sandberg |
Trends in Immunology | 2010 |
|
Selective Serotonin Reuptake Inhibitor Suppression of HIV Infectivity and Replication
T Benton, K Lynch, B Dubé, DR Gettes, NB Tustin, JP Lai, DS Metzger, J Blume, SD Douglas, DL Evans |
Psychosomatic medicine | 2010 |
|
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
VG Fowler, WM Scheld, AS Bayer |
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases | 2010 |
|
Natural Killer Cells
D Mavilio, A Hosmalin, D Scott-Algara |
Natural Killer Cells | 2010 |
|
Emergence of Simian Immunodeficiency Virus-Specific Cytotoxic CD4 + T Cells and Increased Humoral Responses Correlate with Control of Rebounding Viremia in CD8-Depleted Macaques Infected with Rev-Independent Live-Attenuated Simian Immunodeficiency Virus
A von Gegerfelt, A Valentin, C Alicea, KK Rompay, ML Marthas, DC Montefiori, GN Pavlakis, BK Felber |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
|
Emergence of Simian Immunodeficiency Virus-Specific Cytotoxic CD4 + T Cells and Increased Humoral Responses Correlate with Control of Rebounding Viremia in CD8-Depleted Macaques Infected with Rev-Independent Live-Attenuated Simian Immunodeficiency Virus
A von Gegerfelt, A Valentin, C Alicea, KK Rompay, ML Marthas, DC Montefiori, GN Pavlakis, BK Felber |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
|
Natural killer cells: versatile roles in autoimmune and infectious diseases
E Aktas, G Erten, UC Kucuksezer, G Deniz |
Expert Review of Clinical Immunology | 2009 |
|
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
C Fauriat, EO Long, HG Ljunggren, YT Bryceson |
Blood | 2009 |
|
Elevated Natural Killer Cell Activity Despite Altered Functional and Phenotypic Profile in Ugandans With HIV-1 Clade A or Clade D Infection
MA Eller, LA Eller, BJ Ouma, D Thelian, VD Gonzalez, D Guwatudde, FE McCutchan, MA Marovich, NL Michael, MS de Souza, F Wabwire-Mangen, ML Robb, JR Currier, JK Sandberg |
JAIDS Journal of Acquired Immune Deficiency Syndromes | 2009 |
|
Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies
V Holl, M Peressin, C Moog |
Viruses | 2009 |
|
Factores que influyen en el curso de la infección por el virus de la inmunodeficiencia humana tipo 1 en individuos sin progresión a largo plazo
JC Patiño, PA Velilla, MT Rugeles |
Infectio | 2009 |
|
Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines
RH Florese, T Demberg, P Xiao, LR Kuller, K Larsen, LE Summers, D Venzon, A Cafaro, B Ensoli, M Robert-Guroff |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
|
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells
D Scott-Algara, V Arnold, C Didier, T Kattan, G Pirozzi, F Barré-Sinoussi, G Pancino |
PloS one | 2008 |
|
Use of an anti-CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques
EI Choi, R Wang, L Peterson, NL Letvin, KA Reimann |
Immunology | 2008 |
|
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome
DL Evans, KG Lynch, T Benton, B Dubé, DR Gettes, NB Tustin, JP Lai, D Metzger, SD Douglas |
Biological Psychiatry | 2008 |
|
Expansion of CD56− NK cells in chronic HCV/HIV-1 co-infection: Reversion by antiviral treatment with pegylated IFNα and ribavirin
VD Gonzalez, K Falconer, J Michaëlsson, M Moll, O Reichard, A Alaeus, JK Sandberg |
Clinical Immunology | 2008 |
|
Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection
LE Pereira, RP Johnson, AA Ansari |
Cellular Immunology | 2008 |
|
Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication
ST Rasool, H Tang, J Wu, W Li, MM Mukhtar, J Zhang, Y Mu, HX Xing, J Wu, Y Zhu |
Immunology Letters | 2008 |
|
Psychological distress, killer lymphocytes and disease severity in HIV/AIDS
JM Greeson, BE Hurwitz, MM Llabre, N Schneiderman, FJ Penedo, NG Klimas |
Brain, Behavior, and Immunity | 2008 |
|
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2
J Michaëlsson, BR Long, CP Loo, LL Lanier, G Spotts, FM Hecht, DF Nixon |
The Journal of Infectious Diseases | 2008 |
|
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
D Scott-Algara, V Arnold, C Didier, T Kattan, G Pirozzi, F Barré-Sinoussi, G Pancino, DF Nixon |
PloS one | 2008 |
|
Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination
A Iannello, O Debbeche, S Samarani, A Ahmad |
Journal of leukocyte biology | 2008 |
|
In Vivo Natural Killer Cell Depletion during Primary Simian Immunodeficiency Virus Infection in Rhesus Monkeys
EI Choi, KA Reimann, NL Letvin |
Journal of virology | 2008 |
|
Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection
G Kaur, M Tuen, D Virland, S Cohen, NK Mehra, C Münz, S Abdelwahab, A Garzino-Demo, CE Hioe |
Virology | 2007 |
|
Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression
A Crotti, M Lusic, R Lupo, PM Lievens, E Liboi, GD Chiara, M Tinelli, A Lazzarin, BK Patterson, M Giacca, C Bovolenta, G Poli |
Blood | 2007 |
|
Non-neutralizing antibodies and vaccine-induced protection against HIV
RH Florese, M Robert-Guroff |
Future HIV Therapy | 2007 |
|
Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection
J Nilsson, S Kinloch-de-Loes, A Granath, A Sönnerborg, LE Goh, J Andersson |
AIDS | 2007 |
|
Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1
H Harada, Y Goto, T Ohno, S Suzu, S Okada |
European Journal of Immunology | 2007 |
|
Innate Immunity in HIV Infection
S Kottilil, JO Jackson, KN Reitano, MA O??Shea, G Roby, M Lloyd, J Yang, CW Hallahan, CA Rehm, J Arthos, R Lempicki, AS Fauci |
JAIDS Journal of Acquired Immune Deficiency Syndromes | 2007 |
|
Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function
GM O’Connor, A Holmes, F Mulcahy, CM Gardiner |
Clinical Immunology | 2007 |
|
The Biology of Dendritic Cells and HIV Infection
S Gessani, F Belardelli |
2007 | |
|
IMMUNOBIOLOGY OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
P Tripathi, S Agrawal |
Indian Journal of Medical Microbiology | 2007 |
|
Simian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cells
Q Wei, JW Stallworth, PJ Vance, JA Hoxie, PN Fultz |
Clinical and vaccine immunology : CVI | 2006 |
|
Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11
KK van Rompay, EJ Blackwood, G Landucci, D Forthal, ML Marthas |
Virology Journal | 2006 |
|
RANTES (CCL5) regulates airway responsiveness after repeated allergen challenge
T Koya, K Takeda, T Kodama, N Miyahara, S Matsubara, A Balhorn, A Joetham, A Dakhama, EW Gelfand |
American journal of respiratory cell and molecular biology | 2006 |
|
Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells
T Zhang, Y Li, YJ Wang, X Wang, M Young, SD Douglas, WZ Ho |
Antiviral Research | 2006 |
|
Chemokine Biology — Basic Research and Clinical Application
B Moser, GL Letts, K Neote |
2006 | |
|
Innate Immune Dysfunction in HIV Infection: Effect of HIV Envelope-NK Cell Interactions
S Kottilil, K Shin, JO Jackson, KN Reitano, MA OShea, J Yang, CW Hallahan, R Lempicki, J Arthos, AS Fauci |
Journal of immunology (Baltimore, Md. : 1950) | 2006 |
|
Natural Killer Cell Function Is Well Preserved in Asymptomatic Human Immunodeficiency Virus Type 2 (HIV-2) Infection but Similar to That of HIV-1 Infection When CD4 T-Cell Counts Fall
SV Nuvor, M van der Sande, S Rowland-Jones, H Whittle, A Jaye |
Journal of virology | 2006 |
|
Interleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets
JM Roda, R Parihar, A Lehman, A Mani, S Tridandapani, WE Carson |
Journal of immunology (Baltimore, Md. : 1950) | 2006 |
|
Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection
A Miyake, K Ibuki, Y Enose, H Suzuki, R Horiuchi, M Motohara, N Saito, T Nakasone, M Honda, T Watanabe, T Miura, M Hayami |
Journal of General Virology | 2006 |
|
CCL5 Modulates Pneumococcal Immunity and Carriage
R Palaniappan, S Singh, UP Singh, R Singh, EW Ades, DE Briles, SK Hollingshead, W Royal, JS Sampson, JK Stiles, DD Taub, JW Lillard |
Journal of immunology (Baltimore, Md. : 1950) | 2006 |
|
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection
G Alter, N Teigen, BT Davis, MM Addo, TJ Suscovich, MT Waring, H Streeck, MN Johnston, KD Staller, MT Zaman, XG Yu, M Lichterfeld, N Basgoz, ES Rosenberg, M Altfeld |
Blood | 2005 |
|
Large animal models for stem and progenitor cell analysis
RE Donahue, K Kuramoto, CE Dunbar |
Current protocols in immunology / edited by John E. Coligan ... [et al.] | 2005 |
|
Natural-killer cells and dendritic cells: “l'union fait la force”
T Walzer, M Dalod, SH Robbins, L Zitvogel, E Vivier |
Blood | 2005 |
|
Role of cytokines and chemokines in the regulation of innate immunity and HIV infection
M Alfano, G Poli |
Molecular Immunology | 2005 |
|
Antigen-Specific beta-Chemokine Production and CD8+ T-Cell Noncytotoxic Antiviral Activity in HIV-2-Infected Individuals
RK Ahmed, H Norrgren, Z Silva, A Blaxhult, EL Fredriksson, G Biberfeld, S Andersson, R Thorstensson |
Scandinavian Journal of Immunology | 2005 |
|
Innate immunity in experimental SIV infection and vaccination
RK Ahmed, G Biberfeld, R Thorstensson |
Molecular Immunology | 2005 |
|
Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals
D Mavilio, G Lombardo, J Benjamin, D Kim, D Follman, E Marcenaro, MA O'Shea, A Kinter, C Kovacs, A Moretta, AS Fauci |
Proceedings of the National Academy of Sciences | 2005 |
|
NK cells in HIV infection: Paradigm for protection or targets for ambush
AS Fauci, D Mavilio, S Kottilil |
Nature Reviews Immunology | 2005 |
|
Natural killer cell–dendritic cell crosstalk in the initiation of immune responses
T Walzer, M Dalod, E Vivier, L Zitvogel |
Expert Opinion on Biological Therapy | 2005 |
|
The innate immune system and HIV pathogenesis
KA Eger, D Unutmaz |
Current HIV/AIDS Reports | 2005 |
|
Significance of the CC chemokine RANTES in patients with haematological malignancy: results from a prospective observational study
M Ellis, B al-Ramadi, U Hedström, C Frampton, H Alizadeh, J Kristensen |
British Journal of Haematology | 2005 |
|
Alcohol Suppresses IL-2-Induced CC Chemokine Production by Natural Killer Cells
T Zhang, CJ Guo, SD Douglas, DS Metzger, CP O’Brien, Y Li, YJ Wang, X Wang, WZ Ho |
Alcoholism: Clinical and Experimental Research | 2005 |
|
Measuring Immunity
MT Stang, JH Yim |
Measuring Immunity | 2005 |
|
Les mécanismes de résistance à la transmission sexuelle du VIH-1
A Eberhard, B Ponceau, F Biron, B Verrier |
Médecine et Maladies Infectieuses | 2005 |
|
Alcohol Suppresses IL-2–Induced CC Chemokine Production by Natural Killer Cells
T Zhang, CJ Guo, SD Douglas, DS Metzger, CP O’Brien, Y Li, YJ Wang, X Wang, WZ Ho |
Alcoholism, clinical and experimental research | 2005 |
|
Interleukin-15 Increases Effector Memory CD8+ T Cells and NK Cells in Simian Immunodeficiency Virus-Infected Macaques
YM Mueller, C Petrovas, PM Bojczuk, ID Dimitriou, B Beer, P Silvera, F Villinger, JS Cairns, EJ Gracely, MG Lewis, PD Katsikis |
Journal of virology | 2005 |
|
Interactions between Natural Killer Cells and Antibody Fc Result in Enhanced Antibody Neutralization of Human Immunodeficiency Virus Type 1
DN Forthal, G Landucci, TB Phan, J Becerra |
Journal of virology | 2005 |
|
Dendritic Cells and Natural Killer Cells in the Pathogenesis of HIV Infection
C Fortis, G Poli |
Immunologic Research | 2005 |
|
Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity
JJ Lum, DJ Schnepple, Z Nie, J Sanchez-Dardon, GL Mbisa, J Mihowich, N Hawley, S Narayan, JE Kim, DH Lynch, AD Badley |
Journal of virology | 2004 |
|
Control of HIV-1 infection by soluble factors of the immune response
AL DeVico, RC Gallo |
Nature Reviews Microbiology | 2004 |
|
Immune reconstitution
JD Isaacs, A Thiel |
Best Practice & Research Clinical Haematology | 2004 |
|
Perturbation of natural killer cell function and receptors during HIV infection
KA Eger, D Unutmaz |
Trends in Microbiology | 2004 |
|
Neonatal Natural Killer Cells Produce Chemokines and Suppress HIV Replicationin Vitro
HB Bernstein, AL Kinter, R Jackson, AS Fauci |
AIDS Research and Human Retroviruses | 2004 |
|
Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor:
K Muthumani, SA Wadsworth, NS Dayes, DS Hwang, AY Choo, HR Abeysinghe, JJ Siekierka, DB Weiner |
AIDS | 2004 |
|
A novel epitope of N-CAM defines precursors of human adherent NK cells
S Li, J Xu, VP Makarenkova, T Tjandrawan, J Vakkila, T Reichert, W Gooding, CF Lagenaur, CL Achim, WH Chambers, RB Herberman, TL Whiteside, NL Vujanovic |
Journal of leukocyte biology | 2004 |
|
Risk Associated HIV-1 Cross-Clade Resistance of Whole Peripheral Blood Mononuclear Cells From Exposed Uninfected Individuals With Wild-Type CCR5:
R John, S Arango-Jaramillo, GJ Finny, DH Schwartz |
Journal of acquired immune deficiency syndromes (1999) | 2004 |
|
Altered Coexpression of Lectin-Like Receptors CD94 and CD161 on NK and T Cells in HIV Patients
R Jacobs, K Weber, K Wendt, H Heiken, RE Schmidt |
Journal of Clinical Immunology | 2004 |
|
Independent expression of the two paralogous CCL4 genes in monocytes and B lymphocytes
J Lu, M Honczarenko, SR Sloan |
Immunogenetics | 2004 |
|
Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates
D Mavilio, J Benjamin, M Daucher, G Lombardo, S Kottilil, MA Planta, E Marcenaro, C Bottino, L Moretta, A Moretta, AS Fauci |
Proceedings of the National Academy of Sciences | 2003 |
|
Enhancement of Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus
SM Kang, RW Compans |
Journal of virology | 2003 |
|
The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression
C Farquhar, G John-Stewart |
Clinical & Experimental Immunology | 2003 |
|
CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam
LX Truong, TT Luong, D Scott-Algara, P Versmisse, A David, D Perez-Bercoff, NV Nguyen, HK Tran, CT Cao, A Fontanet, JY Follézou, I Theodorou, F Barré-Sinoussi, G Pancino |
AIDS | 2003 |
|
Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone
MR Goodier, N Imami, G Moyle, B Gazzard, F Gotch |
Clinical & Experimental Immunology | 2003 |
|
Interferon-α restores HIV-induced alteration of natural killer cell perforin expression in vivo
P Portales, J Reynes, V Pinet, R Rouzier-Panis, V Baillat, J Clot, P Corbeau |
AIDS | 2003 |
|
A role of the Duffy antigen for the maintenance of plasma chemokine concentrations
N Fukuma, N Akimitsu, H Hamamoto, H Kusuhara, Y Sugiyama, K Sekimizu |
Biochemical and Biophysical Research Communications | 2003 |
|
Association of depression, CD8+ T lymphocytes, and natural killer cell activity: Implications for morbidity and mortality in human immunodeficiency virus disease
DG Cruess, SD Douglas, JM Petitto, J Leserman, TT Have, D Gettes, B Dubé, DL Evans |
Current Psychiatry Reports | 2003 |
|
HIV disease progression: depression, stress, and possible mechanisms
J Leserman |
Biological Psychiatry | 2003 |
|
The Relationships between Substance Abuse, Psychosocial Variables, and Natural Killer Cell Enumeration and Function in HIV-Infected and High-Risk Uninfected Adolescents
SD Douglas, M Camarca, J Xu, S Durako, D Murphy, B Moscicki, CM Wilson |
AIDS Research and Human Retroviruses | 2003 |
|
The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy:
J Tang, RA Kaslow |
AIDS | 2003 |
|
Depression and HIV Infection: Impact on Immune Function and Disease Progression
DG Cruess, JM Petitto, J Leserman, SD Douglas, DR Gettes, TR Have, DL Evans |
CNS Spectrums | 2003 |
|
G protein-coupled receptors in natural killer cells
AA Maghazachi |
Journal of leukocyte biology | 2003 |
|
Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of ?-chemokines in contrast to infected humans
P Ondoa, C Vereecken, K Fransen, R Colebunders, G van der Groen, JL Heeney, L Kestens |
Journal of Medical Virology | 2003 |
|
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
D Scott-Algara, LX Truong, P Versmisse, A David, TT Luong, NV Nguyen, I Theodorou, F Barré-Sinoussi, G Pancino |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
|
Macrophage inflammatory protein-1
P Menten, A Wuyts, JV Damme |
Cytokine & Growth Factor Reviews | 2002 |
|
Uncoupling activation-induced modulation of CD16 and CD69 in CD56+ cells during AIDS
JM Barboza, S Salmen, JA Cova, B Albarran, L Goncalves, L Borges, M Hernandez, L Berrueta |
APMIS | 2002 |
|
A comparative investigation of CC chemokines and SIV suppressor factors generated by CD8+ and CD4+ T cells and CD14+ monocytes
K Babaahmady, LA Bergmeier, T Whittall, M Singh, Y Wang, T Lehner |
Journal of Immunological Methods | 2002 |
|
In vitro replication of SIVcpz is suppressed by beta-chemokines and CD8+ T cells but not by natural killer cells of infected chimpanzees
P Ondoa, J Vingerhoets, C Vereecken, G der Groen, JL Heeney, L Kestens |
AIDS Research and Human Retroviruses | 2002 |
|
AIDS Vaccine Research
V Lukashov, J Goudsmit, W Paxton |
AIDS Vaccine Research | 2002 |
|
IL-2 and IL-12 Alter NK Cell Responsiveness to IFN-γ-Inducible Protein 10 by Down-Regulating CXCR3 Expression
DL Hodge, WB Schill, JM Wang, I Blanca, DA Reynolds, JR Ortaldo, HA Young |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
|
Sustained Impairment of IFN-γ Secretion in Suppressed HIV-Infected Patients Despite Mature NK Cell Recovery: Evidence for a Defective Reconstitution of Innate Immunity
L Azzoni, E Papasavvas, J Chehimi, JR Kostman, K Mounzer, J Ondercin, B Perussia, LJ Montaner |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
|
Natural Killer Cell Enumeration and Function in HIV-Infected and High-Risk Uninfected Adolescents
SD Douglas, SJ Durako, NB Tustin, J Houser, L Muenz, SE Starr, C Wilson |
AIDS Research and Human Retroviruses | 2001 |
|
Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells
DN Forthal, G Landucci, ES Daar |
Journal of virology | 2001 |
|
Ontogeny and Expansion of Human Natural Killer Cells: Clinical Implications
TA Fehniger, MA Caligiuri |
International Reviews of Immunology | 2001 |
|
NK cells and NKT cells in innate defense against viral infections
CA Biron, L Brossay |
Current Opinion in Immunology | 2001 |
|
Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion
V Daniel, C Süsal, R Weimer, R Zimmermann, A Huth-Kühne, G Opelz |
Immunology Letters | 2001 |
|
Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts
G Ironson, E Balbin, G Solomon, J Fahey, N Klimas, N Schneiderman, MA Fletcher |
AIDS | 2001 |
|
New T-lymphocytic cell lines for studying cell infectability by human immunodeficiency virus
T Rozmyslowicz, J Kijowski, DO Conover, M Majka, M Baj-Krzyworzeka, R Reca, JJ Libura, GN Gaulton, MZ Ratajczak |
European Journal of Haematology | 2001 |
|
Relationship between Antibody-Dependent Cellular Cytotoxicity, Plasma HIV Type 1 RNA, and CD4+Lymphocyte Count
DN Forthal, G Landucci, B Keenan |
AIDS Research and Human Retroviruses | 2001 |
|
RANTES and MIP-1β mRNA expression in human peripheral blood mononuclear cells: transcript quantification using NASBA technology
JW Romano, RN Shurtliff, EM Lee, R Cornelison, S Than, MH Kaplan, CC Ginocchio |
Journal of Immunological Methods | 2001 |
|
RANTES potentiates antigen-specific mucosal immune responses
JW Lillard, PN Boyaka, DD Taub, JR McGhee |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
|
MACROPHAGE-DERIVED CHEMOKINE GENE EXPRESSION IN HUMAN AND MACAQUE CELLS: mRNA QUANTIFICATION USING NASBA TECHNOLOGY
JW Romano, RN Shurtliff, M Grace, EM Lee, C Ginocchio, M Kaplan, R Pal |
Cytokine | 2001 |
|
Activity of natural killer cells during HIV-1 infection in Brazilian patients
DF Nunes, A Carvalho, AJ da Duarte |
Revista do Hospital das Clínicas | 2001 |
|
Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients
R Ahmad, ST Sindhu, P Tran, E Toma, R Morisset, J Menezes, A Ahmad |
Journal of Medical Virology | 2001 |
|
Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner
M Majka, A Janowska-Wieczorek, J Ratajczak, K Ehrenman, Z Pietrzkowski, MA Kowalska, AM Gewirtz, SG Emerson, MZ Ratajczak |
Blood | 2001 |
|
CD8+Cell Lines Isolated from HIV-1–Infected Children Have Potent Soluble HIV-1 Inhibitory Activity That Differs from β-Chemokines
A Mosoian, A Teixeira, E Caron, J Piwoz, M Klotman |
Viral Immunology | 2000 |
|
Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin
P André, O Spertini, S Guia, P Rihet, F Dignat-George, H Brailly, J Sampol, PJ Anderson, E Vivier |
Proceedings of the National Academy of Sciences | 2000 |
|
In vitro correlates of HIV-2-mediated HIV-1 protection
EG Kokkotou, JL Sankale, I Mani, A Gueye-Ndiaye, D Schwartz, ME Essex, S Mboup, PJ Kanki |
Proceedings of the National Academy of Sciences | 2000 |
|
The limited infectability by R5 HIV of CD34+ cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce β-chemokines
M Majka, T Rozmyslowicz, J Ratajczak, A Dobrowsky, Z Pietrzkowski, GN Gaulton, A Janowska-Wieczorek, MZ Ratajczak |
Experimental Hematology | 2000 |
|
Reconstitution of NK Cell Activity in HIV-1 Infected Individuals Receiving Antiretroviral Therapy
K Weber, D Meyer, V Grosse, M Stoll, RE Schmidt, H Heiken |
Immunobiology | 2000 |
|
Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines
M Majka, T Rozmyslowicz, M Honczarenko, J Ratajczak, MA Wasik, GN Gaulton, MZ Ratajczak |
Leukemia | 2000 |
|
The pathogenesis of tropical spastic paraparesis/human T-cell leukemia type I-associated myelopathy
J Casseb, AC Penalva-de-Oliveira |
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] | 2000 |
|
Human NK Cells Express CC Chemokine Receptors 4 and 8 and Respond to Thymus and Activation-Regulated Chemokine, Macrophage-Derived Chemokine, and I-309
M Inngjerdingen, B Damaj, AA Maghazachi |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
|
AIDS Pathogenesis
H Schuitemaker, F Miedema |
2000 | |
|
Evaluation of Natural Killer Cell Activity
JH Cox, M deSouza |
Molecular Biotechnology | 2000 |
|
Bone marrow CD34+ cells and megakaryoblasts secrete β-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV
M Majka, T Rozmyslowicz, B Lee, SL Murphy, Z Pietrzkowski, GN Gaulton, L Silberstein, MZ Ratajczak |
Journal of Clinical Investigation | 1999 |
|
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
CA Biron, KB Nguyen, GC Pien, LP Cousens, TP Salazar-Mather |
Annual Review of Immunology | 1999 |
|
Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status
A Garzino-Demo, RB Moss, JB Margolick, F Cleghorn, A Sill, WA Blattner, F Cocchi, DJ Carlo, AL DeVico, RC Gallo |
Proceedings of the National Academy of Sciences | 1999 |
|
Cytokines in the evolution and treatment of AIDS-lymphoma
RA Baiocchi, MA Caligiuri |
Current Opinion in Oncology | 1999 |
|
Role of Peripheral Blood Mononuclear Cell Subsets of Seronegative Donors in HIV Replication: Suppression by CD8+ and CD16+ Cells and Enhancement by CD14+ Monocytes
M Alfano, F Veglia, G Poli |
AIDS Research and Human Retroviruses | 1999 |
|
Stress and coping: the psychoneuroimmunology of HIV/AIDS
EG Balbin, GH Ironson, GF Solomon |
Best Practice & Research Clinical Endocrinology & Metabolism | 1999 |
|
Les tentatives de mise au point d'un vaccin sous-unitaire contre le sida
R Daudel, L Montagnier |
Comptes Rendus de l'Académie des Sciences - Series IIC - Chemistry | 1999 |
|
Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals
P André, C Brunet, S Guia, H Gallais, J Sampol, E Vivier, F Dignat-George |
European Journal of Immunology | 1999 |
|
Dual role of TNF-α in NK / LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysis
C Fortis, P Biswas, L Soldini, F Veglia, AM Careddu, F Delfanti, B Mantelli, M Murone, A Lazzarin, G Poli |
European Journal of Immunology | 1999 |
|
Interleukin-15 as an activator of natural killer cell-mediated antiviral response
J Gosselin, A TomoIu, RC Gallo, L Flamand |
Blood | 1999 |
|
HIV infection and pathogenesis: what about chemokines?
R C Gallo, A Garzino-Demo, A L DeVico |
Journal of Clinical Immunology | 1999 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)